Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Adherium Ltd. ( (AU:ADR) ) is now available.
Adherium Ltd. has announced the issuance of 66,208,082 unquoted securities, set to expire on July 31, 2026, with an exercise price of $0.005. This strategic move, part of a previously announced transaction, is expected to enhance the company’s capital structure and support its ongoing initiatives in digital health technology, potentially impacting its market positioning positively.
More about Adherium Ltd.
Adherium Ltd. operates in the healthcare industry, focusing on developing digital health technologies. The company specializes in providing solutions for remote monitoring and management of respiratory conditions, aiming to improve patient adherence to prescribed therapies.
Technical Sentiment Signal: Sell
Current Market Cap: A$8.98M
For detailed information about ADR stock, go to TipRanks’ Stock Analysis page.